Skip to main content

Search form

  • Log in
  • Membership
  • Advertise
  • eKnowledgeBase
Pharmalive

Pharmalive

  • Business

    Featured Story

    Royalty Pharma Increases Bid for Elan

    Royalty says it will pay $12.50 in cash for each share of Elan.

    Read More

    Recent Business Stories

    Actavis to Buy Warner Chilcott in $8.5B Deal
    UCB, IBM Collaborate to Personalize Care for...
    Bayer to Acquire Steigerwald...
    TNI BioTech, Inc. Corporation's CEO...
    Ambit Biosciences Announces Pricing of...
    EntreMed Reports First Quarter 2013...

    Quick LInks

    • Podcasts
    • Special Reports
    • Webinars
    • White Papers
    Stay
  • Marketing & Advertising

    Featured Story

    Modern Family Star Kicks Off Mylan Anaphylaxis Campaign

    "Modern Family" Star Julie Bowen Calls on Communities to Raise Their Hand for Anaphylaxis Awareness in Nationwide Competition Total of $60,000 Will...

    Read More

    Recent Marketing & Advertising Stories

    IFPMA Launches 'Do You Mind?'...
    Glaxo Hit the Most By Drug Price Control...
    Healthcare Providers at Lilly Play Important...
    Sanofi Taps Jerome Bettis to Tackle...
    Novo Nordisk, Paula Deen Announce Contest...
    Sudler’s ehealth Group Signs Agreement With...

    Quick Links

    • Podcasts
    • Special Reports
    • Webinars
    • White Papers
    • Marketing Directory
    • Med Ad News Archives
    Stay
  • R&D

    Featured Story

    FDA, Peregrine Agree on Phase III Bavituximab Study

    Peregrine rises on agreement for late-stage study WASHINGTON (AP) — Shares of Peregrine Pharmaceuticals Inc. surged Monday after the company said it...

    Read More

    R&D Recent Stories

    FDA Grants 'Breakthrough'...
    XenoPort Phase III MS Drug Misses Endpoint
    Neuralstem ALS Trial Principal Investigator...
    Takeda, Lundbeck Phase III Drug Helps...
    Tracon Announces TRC105 Clinical Trials at...
    Healthcare Providers at Lilly Play Important...

    Quick Links

    • Podcasts
    • Special Reports
    • Webinars
    • White Papers
    • CRO Directory
    • R&D Directions Archives
    Stay
  • Therapeutics

    Featured Story

    Pfizer Halts Study of Non-Hodgkin's Lymphoma Drug

    An interim analysis showed the drug wasn't helping patients live longer

    Read More

    Therapeutics Recent Stories

    FDA, Peregrine Agree on Phase III...
    Takeda, Lundbeck Phase III Drug Helps...
    FDA OKs Simponi for Ulcerative Colitis...
    Gilead Sciences Reports Good Phase II Data...
    Roche: Phase III Leukemia Drug '...
    AstraZeneca Moves 3 Cancer Compounds to...

    Quick Links

    • Podcasts
    • Special Reports
    • Webinars
    • White Papers
    Stay
  • Pharmalot

    Featured Story

    J&J Asks Employees To Assess Its Battered Corporate Credo

    In the wake of scandals and investigations over manufacturing gaffes, countless product recalls and questionable marketing practices, Johnson &...

    Read More

    Recent Stories

    Ranbaxy Whistleblower: So Many Infractions...
    Hopes For Autism And Fragile X Drug Dashed...
    France Says 'Non!' To EMA Over...
    Pharmalot... Pharmalittle... Good Morning
    Bristol-Myers Is Fined For Monkey Deaths,...
    The Soprano Wanna-Bees Are Stealing More...

    Quick Links

    • Podcasts
    • Special Reports
    • Webinars
    • White Papers
    Stay
  • Resources

    Featured Resource

    Connecting with customers: how you can create sustainable competitive advantage in the changing life sciences industry.

    This paper focuses on how customer centricity can unlock significant financial gains for...Read more

    Recent Resources

    Connecting with customers: how you can create...
    Early Planning Essential: Best Practices in Late...
    In Pursuit of Patient Adherence
    Analytics in Managed Markets: Negotiate Like a Pro
    A New Approach to Outsourced Drug Development:...
    Best Practices to Ensure Successful Sponsor and...
    Favorable Regulatory Procedures in the Netherlands

    Quick Links

    • Podcasts
    • Special Reports
    • Webinars
    • White Papers
    • CRO Directory
    • Marketing Directory
    Stay
  • Directories

    Marketing Communications Directory

    Healthcare Communications Agencies & Marketing Services Directory

    Browse Companies
    Companies A-Z
    List your Organization

    Contract Research Directory

    Qualified Clinical Research Organizations Directory

    Browse Companies
    Companies A-Z
    List your Organization
    Stay
  • Manny Awards
  • Events
  • Jobs

    Latest Job Posting

    Quality Assurance Compliance Specialist

    Technical Resources International Inc. - Bethesda MD (1 month 3 weeks ago)

    Founded in 1979, Technical Resources International, Inc. (TRI) provides a unique range of support services in the areas of Communications, Health and Information Technology to both private industry and government agency clients. TRI is currently seeking a Quality Assurance (QA) Compliance Specialist to join our...

    Read More

    More Jobs

    Director/Senior Director of Human Resources
    Become a Science Teacher
    Research Associate / Sr. Research Associate Protein Chemistry
    Predoctoral Researcher
    Experienced Clinical Project Manager
    Technical Operations Oracle IT Analyst Job
    View all Jobs
    Stay

You are here

Home » Pharmalot » Pharmalot...Pharmalittle...

Pharmalot...Pharmalittle...

Posted Thu, 06/07/2007 - 1:38pm by Ed Silverman 0
Lilly To Appeal Zyprexa Rulings In Canada & Germany (Yahoo/Reuters)

Johnson & Johnson Plans To File Five New Compounds (MarketWatch)

Teva Plans Late-Stage Studies For MS Drug (Yahoo/AP)

Medco Stock Boosted By Government Contract (MarketWatch)

AstraZeneca Promotes Two Execs In Asia (moneycontrol.com)

Par Pharma Names New CFO (Yahoo/Reuters)

Tweet
  • Log in or register to post comments

Latest Stories

J&J Asks Employees To Assess Its Battered Corporate Credo
Ranbaxy Whistleblower: So Many Infractions And Each Was Egregious
Hopes For Autism And Fragile X Drug Dashed By Little Biotech Struggles
France Says 'Non!' To EMA Over Bayer Acne Pill
Pharmalot... Pharmalittle... Good Morning
Bristol-Myers Is Fined For Monkey Deaths, But Will $2,600 Matter?
The Soprano Wanna-Bees Are Stealing More Drugs This Year
Actavis 'Moves' To Ireland For A Lower Tax Rate
A Non-Profit, A Vertex Drug And Conflicts Of Interest
Pharmalot... Pharmalittle... Good Morning

About Ed Silverman

Ed Silverman is a prize-winning journalist who has covered the pharmaceutical industry for the past 18 years. In addition to editing Pharmalot, he is currently an editor-at-large for Med Ad News.

Read more

© 2012 UBM Canon

Site Information

  • About Us
  • Terms of Use
  • Privacy Policy

Follow Us

Find Pharmalive on TwitterFind Pharmalive on FacebookFind Pharmalive on LinkedInPharmalive RSS feed

Site Navigation

  • Home
  • Business
  • Marketing & Advertising
  • R&D
  • Therapeutics
  • Pharmalot
  • Resources
  • Directories
  • Manny Awards
  • Events
  • Jobs
array (
  'excluded' => 
  array (
    'uid' => false,
    'page' => false,
  ),
)